469867-29-6Relevant articles and documents
MUCIN SYNTHESIS INHIBITORS
-
Page 26-28, (2010/02/10)
The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases.